vimarsana.com
  1. Home
  2. Live Updates
  3. Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts : vimarsana.com

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts

Vera Therapeutics, Inc. (NASDAQ:VERA) Receives $28.14 Average Target Price from Analysts

theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.

Related Keywords

Raymond James , Maha Katabi , Barclays Plc , Capital Partners , Vera Therapeutics Company Profile , Goldman Sachs Group Inc , Nasdaq , Vanguard Group Inc , Vera Therapeutics Inc , Cantor Fitzgerald , Vera Therapeutics , Get Free Report , Therapeutics Trading Down , Director Maha Katabi , Sachs Group , Get Free , Vera Therapeutics Daily ,

© 2024 Vimarsana

vimarsana.com © 2020. All Rights Reserved.